DexCom Pre-Tax Income 2010-2025 | DXCM

DexCom pre-tax income for the twelve months ending March 31, 2025 was $0.731B, a 6.12% decline year-over-year.

  • DexCom annual pre-tax income for 2024 was $0.709B, a 0.2% decline from 2023.
  • DexCom annual pre-tax income for 2023 was $0.71B, a 81.78% increase from 2022.
  • DexCom annual pre-tax income for 2022 was $0.391B, a 52.18% increase from 2021.

DexCom Pre-Tax Income 2010-2025 | DXCM

  • DexCom annual pre-tax income for 2024 was $0.709B, a 0.2% decline from 2023.
  • DexCom annual pre-tax income for 2023 was $0.71B, a 81.78% increase from 2022.
  • DexCom annual pre-tax income for 2022 was $0.391B, a 52.18% increase from 2021.
Related Stocks
Company NameMarket
Cap
Intuitive Surgical (ISRG)$183.2B
Thermo Fisher Scientific (TMO)$161.4B
Edwards Lifesciences (EW)$44.8B
Alcon (ALC)$43.7B
IDEXX Laboratories (IDXX)$42.8B
IQVIA Holdings (IQV)$32.4B
Mettler-Toledo (MTD)$25.3B
STERIS (STE)$22B
SONOVA HOLDING (SONVY)$17.4B
Waters (WAT)$17.1B
Hologic (HOLX)$14.6B
Sysmex ADR (SSMXY)$10.2B
Penumbra (PEN)$9B
Masimo (MASI)$8.6B
Globus Medical (GMED)$7.2B
Glaukos (GKOS)$5.5B
Teleflex (TFX)$5.1B
Integer Holdings (ITGR)$4B
TransMedics (TMDX)$3.6B
PROCEPT BioRobotics (PRCT)$3.3B
LivaNova (LIVN)$2.4B
Nihon Kohden (NHNKY)$2.1B
Elekta AB (EKTAY)$1.9B
Veracyte (VCYT)$1.8B
Alphatec Holdings (ATEC)$1.6B
Artivion (AORT)$1.3B
Paragon 28 (FNA)$1.1B
OPKO Health (OPK)$1.1B
Pulse Biosciences (PLSE)$1B
Tandem Diabetes Care (TNDM)$1B